Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Side-effect Management for Patients With Malignant Melanoma Undergoing Treatment With Interferon Alpha (IFN-α)- Diagnosis and Therapy -

NCT00963261 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.

NCT NCT00963261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00963261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Side-effect Management for Patients With Malignant Melanoma Undergoing Treatment With Interferon Alpha (IFN-α)- Diagnosis and Therapy -
Lead sponsor
University Hospital Freiburg
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2009
Completion date
April 30, 2012
Enrollment
600 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma